XML 58 R36.htm IDEA: XBRL DOCUMENT v3.22.0.1
Basis of Presentation and Significant Accounting Policies (Tables)
5 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2020
Sep. 30, 2021
Dec. 31, 2021
Basis of Presentation and Significant Accounting Policies (Tables) [Line Items]      
Schedule of basic and diluted net loss per share for each class of common stock
 

For the period from August 11,
2020 (inception) through
December 31, 2020

   

Class A

 

Class B

Basic and diluted net loss per common share:

 

 

 

 

 

 

 

 

Numerator:

 

 

 

 

 

 

 

 

Allocation of net loss

 

$

(2,841,640

)

 

$

(1,381,893

)

   

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

 

 

Basic and diluted weighted average common shares outstanding

 

 

5,911,972

 

 

 

2,875,000

 

Basic and diluted net loss per common share

 

$

(0.48

)

 

$

(0.48

)

 

For the Three Months
Ended
September 30, 2021

 

For the Nine Months
Ended
September 30, 2021

 

For the
Period from
August 11 (Inception) to
September 30,
2020

   
   

Class A

 

Class B

 

Class A

 

Class B

 

Class B

Basic and diluted net income (loss) per common share:

 

 

   

 

   

 

 

 

 

 

 

 

 

 

 

 

Numerator:

 

 

   

 

   

 

 

 

 

 

 

 

 

 

 

 

Allocation of net income (loss)

 

$

479,385

 

$

65,102

 

$

(420,345

)

 

$

(87,867

)

 

$

(2,065

)

Denominator:

 

 

   

 

   

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted weighted average common shares outstanding

 

 

27,600,000

 

 

3,066,666

 

 

26,184,615

 

 

 

3,046,153

 

 

 

 

 

Basic and diluted net income (loss) per common share

 

$

0.04

 

$

0.04

 

$

(0.04

)

 

$

(0.04

)

 

$

 

 
Schedule of financial statement
 

As
Previously Reported

 

Adjustments

 

As Restated

Balance sheet as of October 19, 2020 (audited)

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liabilities

 

$

 

 

$

5,157,000

 

 

$

5,157,000

 

Class A common stock subject to possible redemption

 

 

107,104,620

 

 

 

(5,157,000

)

 

 

101,947,620

 

Class A common stock

 

 

79

 

 

 

52

 

 

 

131

 

Additional paid-in capital

 

 

5,004,204

 

 

 

191,060

 

 

 

5,195,264

 

Accumulated deficit

 

 

(4,608

)

 

 

(191,112

)

 

 

(195,720

)

   

 

 

 

 

 

 

 

 

 

 

 

Balance sheet as of December 31, 2020 (audited)

 

 

 

 

 

 

 

 

 

 

 

 

Warrant liabilities

 

$

 

 

$

9,040,670

 

 

$

9,040,670

 

Class A common stock subject to possible redemption

 

 

106,882,750

 

 

 

(9,040,670

)

 

 

97,842,080

 

Class A common stock

 

 

81

 

 

 

91

 

 

 

172

 

Additional paid-in capital

 

 

5,148,390

 

 

 

4,074,691

 

 

 

9,223,081

 

Accumulated deficit

 

 

(148,751

)

 

 

(4,074,782

)

 

 

(4,223,533

)

   

 

 

 

 

 

 

 

 

 

 

 

Statement of Operations for the period from August 11, 2020 (inception) to December 31, 2020 (audited)

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of warrant liabilities

 

$

 

 

$

3,883,670

 

 

$

3,883,670

 

Offering expense associated with warrant liabilities

 

 

 

 

 

191,112

 

 

 

191,112

 

Net loss

 

 

(148,751

)

 

 

(4,074,782

)

 

 

(4,223,533

)

Basic and diluted net loss per share, Class B common stock

 

 

(0.06

)

 

 

(1.42

)

 

 

(1.48

)

   

 

 

 

 

 

 

 

 

 

 

 

Statement of Cash Flows for the period from August 11, 2020 (inception) to December 31, 2020 (audited)

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(148,751

)

 

$

(4,074,782

)

 

$

(4,223,533

)

Offering costs allocable to warrant liabilities

 

 

 

 

 

191,112

 

 

 

191,112

 

Change in fair value of warrant liabilities

 

 

 

 

 

3,883,670

 

 

 

3,883,670

 

Initial classification of Class A common shares subject to possible redemption

 

 

107,104,620

 

 

 

(5,157,000

)

 

 

101,947,620

 

Change in value of Class A common shares subject to possible redemption

 

 

(221,870

)

 

 

(3,883,670

)

 

 

(4,105,540

)

Balance sheet as of October 19, 2020 (audited)

 

As Previously
Restated and
Reported in
Form 10-K/A
Amendment
No. 1

 

Adjustments

 

As Restated

Total assets

 

$

116,390,976

 

 

 

 

 

$

116,390,976

 

Total liabilities

 

$

9,443,350

 

 

 

 

 

$

9,443,350

 

Class A common stock subject to possible redemption

 

 

101,947,620

 

 

 

13,052,380

 

 

 

115,000,000

 

Preferred stock

 

 

 

 

 

 

 

 

 

Class A common stock

 

 

131

 

 

 

(131

)

 

 

 

Class B common stock

 

 

331

 

 

 

 

 

 

331

 

Additional paid-in capital

 

 

5,195,264

 

 

 

(5,195,264

)

 

 

 

Accumulated deficit

 

 

(195,720

)

 

 

(7,856,985

)

 

 

(8,052,705

)

Total stockholders’ equity (deficit)

 

$

5,000,006

 

 

$

(13,052,380

)

 

$

(8,052,374

)

Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Equity (Deficit)

 

$

116,390,976

 

 

$

 

 

$

116,390,976

 

Balance sheet as of December 31, 2020 (audited)

 

As Previously
Restated and
Reported in
Form 10-K/A
Amendment
No. 1

 

Adjustments

 

As Restated

Total assets

 

$

116,067,608

 

 

 

 

 

$

116,067,608

 

Total liabilities

 

$

13,225,520

 

 

 

 

 

$

13,225,520

 

Class A common stock subject to possible redemption

 

 

97,842,080

 

 

 

17,157,920

 

 

 

115,000,000

 

Preferred stock

 

 

 

 

 

 

 

 

 

Class A common stock

 

 

172

 

 

 

(172

)

 

 

 

Class B common stock

 

 

288

 

 

 

 

 

 

288

 

Additional paid-in capital

 

 

9,223,081

 

 

 

(9,223,081

)

 

 

 

Accumulated deficit

 

 

(4,223,533

)

 

 

(7,934,667

)

 

 

(12,158,200

)

Total stockholders’ equity (deficit)

 

$

5,000,008

 

 

$

(17,157,920

)

 

$

(12,157,912

)

Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’ Equity (Deficit)

 

$

116,067,608

 

 

$

 

 

$

116,067,608

 

For the Period From August 11, 2020 (Inception) Through December 31, 2020

 

As Previously
Restated and
Reported in
Form 10-K/A
Amendment
No. 1

 

Adjustments

 

As Restated

Supplemental Disclosure of Noncash Financing Activities:

 

 

 

 

 

 

 

 

 

 

 

Initial value of Class A common stock subject to possible redemption

 

$

101,947,620

 

 

$

(101,947,620

)

 

$

Change in value of Class A common stock subject to possible redemption

 

$

(4,105,540

)

 

$

4,105,540

 

 

$

 

Net Loss Per Share

For the Period From August 11, 2020 (Inception) Through December 31, 2020

 

As Previously Restated and Reported in Form 10-K/A Amendment No. 1

 

Adjustments

 

As Restated

Net loss

 

$

(4,223,533

)

 

$

 

 

$

(4,223,533

)

Weighted average shares outstanding – Class A common stock

 

 

11,500,000

 

 

 

(5,588,028

)

 

 

5,911,972

 

Basic and diluted net loss per share – Class A common stock

 

$

0.00

 

 

$

(0.48

)

 

$

(0.48

)

Weighted average shares outstanding – Class B common stock

 

 

2,875,000

 

 

 

 

 

 

2,875,000

 

Basic and diluted net loss per share – Class B common stock

 

$

(1.48

)

 

$

1.00

 

 

$

(0.48

)

 

As Previously Reported

 

Adjustments

 

As Restated

Balance sheet as of March 31, 2021 (unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

$

115,725,964

 

 

 

 

 

$

115,725,964

 

Total liabilities

 

$

10,894,008

 

 

 

 

 

$

10,894,008

 

Class A common stock subject to possible redemption

 

 

99,831,950

 

 

 

15,168,050

 

 

 

115,000,000

 

Preferred stock

 

 

 

 

 

 

 

 

 

Class A common stock

 

 

152

 

 

 

(152

)

 

 

 

Class B common stock

 

 

288

 

 

 

 

 

 

288

 

Additional paid-in capital

 

 

7,233,231

 

 

 

(7,233,231

)

 

 

 

Accumulated deficit

 

 

(2,233,665

)

 

 

(7,934,667

)

 

 

(10,168,332

)

Total stockholders’ equity (deficit)

 

$

5,000,006

 

 

$

(15,168,050

)

 

$

(10,168,044

)

Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’
Equity (Deficit)

 

$

115,725,964

 

 

$

 

 

$

115,725,964

 

 

As Previously Reported

 

Adjustments

 

As Restated

Balance sheet as of June 30, 2021 (unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

Total assets

 

$

115,464,516

 

 

 

 

 

$

115,464,516

 

Total liabilities

 

$

13,675,127

 

 

 

 

 

$

13,675,127

 

Class A common stock subject to possible redemption

 

 

96,789,380

 

 

 

18,210,620

 

 

 

115,000,000

 

Preferred stock

 

 

 

 

 

 

 

 

 

Class A common stock

 

 

182

 

 

 

(182

)

 

 

 

Class B common stock

 

 

288

 

 

 

 

 

 

288

 

Additional paid-in capital

 

 

10,275,771

 

 

 

(10,275,771

)

 

 

 

Accumulated deficit

 

 

(5,276,232

)

 

 

(7,934,667

)

 

 

(13,210,899

)

Total stockholders’ equity (deficit)

 

$

5,000,009

 

 

$

(18,210,620

)

 

$

(13,210,611

)

Total Liabilities, Class A Common Stock Subject to Possible Redemption and Stockholders’
Equity (Deficit)

 

$

115,464,516

 

 

$

 

 

$

115,464,516

 

 
Schedule of supplemental disclosure of noncash financing activities  
 

As Previously Reported

 

Adjustments

 

As Restated

Supplemental Disclosure of Noncash Financing Activities:

 

 

   

 

 

 

 

 

 

Change in value of Class A common stock subject to possible redemption

 

$

1,989,870

 

$

(1,989,870

)

 

$

 

As Previously Reported

 

Adjustments

 

As Restated

Supplemental Disclosure of Noncash Financing Activities:

 

 

 

 

 

 

   

 

 

Change in value of Class A common stock subject to possible redemption

 

$

(1,052,700

)

 

$

1,052,700

 

$

 
Schedule of weighted average shares outstanding and basic and diluted net income (loss) per common share  
 

Net Income Per Share

   

As Reported

 

Adjustment

 

As Restated

Three Months Ended March 31, 2021 (Unaudited)

 

 

   

 

 

 

 

 

 

Net income

 

$

1,989,868

 

$

 

 

$

1,989,868

Weighted average shares outstanding – Class A common stock

 

 

11,500,000

 

 

 

 

 

11,500,000

Basic and diluted net income per share – Class A common stock

 

$

0.00

 

$

0.14

 

 

$

0.14

Weighted average shares outstanding – Class B common stock

 

 

2,875,000

 

 

 

 

 

2,875,000

Basic and diluted net income per share – Class B common stock

 

$

0.69

 

$

(0.55

)

 

$

0.14

 

Net Loss Per Share

   

As Reported

 

Adjustment

 

As Restated

Three Months Ended June 30, 2021 (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(3,042,567

)

 

$

 

 

$

(3,042,567

)

Weighted average shares outstanding – Class A common stock

 

 

11,500,000

 

 

 

 

 

 

11,500,000

 

Basic and diluted net loss per share – Class A common stock

 

$

0.00

 

 

$

(0.21

)

 

$

(0.21

)

Weighted average shares outstanding – Class B common stock

 

 

2,875,000

 

 

 

 

 

 

2,875,000

 

Basic and diluted net loss per share – Class B common stock

 

$

(1.06

)

 

$

0.85

 

 

$

(0.21

)

 

Net Loss Per Share

   

As Reported

 

Adjustment

 

As Restated

Six Months Ended June 30, 2021 (Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(1,052,699

)

 

$

 

 

$

(1,052,699

)

Weighted average shares outstanding – Class A common stock

 

 

11,500,000

 

 

 

 

 

 

11,500,000

 

Basic and diluted net loss per share – Class A common stock

 

$

0.00

 

 

$

(0.07

)

 

$

(0.07

)

Weighted average shares outstanding – Class B common stock

 

 

2,875,000

 

 

 

 

 

 

2,875,000

 

Basic and diluted net loss per share – Class B common stock

 

$

(0.37

)

 

$

0.30

 

 

$

(0.07

)

 
DocGo Inc. and Subsidiaries [Member]      
Basis of Presentation and Significant Accounting Policies (Tables) [Line Items]      
Summary of estimated useful live    

Asset Category

 

Estimated Useful Lives

Buildings

 

39 years

Office equipment and furniture

 

3 years

Vehicles

 

5 – 8 years

Medical equipment

 

5 years

Leasehold improvements

 

Shorter of useful life of asset or lease term

Schedule of revenue disaggregated    
 

Years Ended December 31,

   

2021

 

2020

Primary Geographical Markets

 

 

   

 

 

United States

 

$

309,218,594

 

$

88,362,445

United Kingdom

 

 

9,499,986

 

 

5,728,213

Total revenue

 

$

318,718,580

 

$

94,090,658

Major Segments/Service Lines

 

 

   

 

 

Transportation Services

 

$

84,268,817

 

$

63,188,855

Mobile Health

 

 

234,449,763

 

 

30,901,803

Total revenue

 

$

318,718,580

 

$

94,090,658